Skip to content
News

Duke School of Medicine Soars to Seventh in 2023 Blue Ridge Ranking

February 13, 2024 | By Shantell M. Kirkendoll

Originally published by Duke University School of Medicine


Duke University School of Medicine surged to seventh place on the 2023 Blue Ridge Institute for Medical Research (BRIMR) ranking based on its National Institutes of Health funding which grew to $551 million. 

The rise in ranking from ninth place the previous year exemplifies the School of Medicine’s growing influence in researching ways to make the nation healthier. 

“This remarkable achievement is a result of the dedication and innovation of our incredible faculty and researchers,” said Mary E. Klotman, MD, executive vice president for health affairs and dean of Duke University School of Medicine. “Their passion and expertise are key to Duke’s role in shaping the future of health care and delivering life-saving discoveries.”    

Each February the Blue Ridge Institute for Medical Research publishes its rankings of institutions, departments, and investigators based on the funding they receive from the NIH.  

This year's ranking analyzed data from the 2023 federal fiscal year ending September 30, 2023.  

Duke University ranked fifth, garnering $701 million in total grants and research and development contracts from the NIH in 2023. 

This year’s Blue Ridge rankings revealed Duke’s research strength across diverse research areas with nine clinical science departments and two basic science departments at the School of Medicine among the top 10 in the country.  

  • 1st Pediatrics                                                    
  • 1st Orthopedics                                                                
  • 1st Surgery                                                    
  • 3rd Anesthesiology                                        
  • 5th Pharmacology    
  • 6th Internal Medicine    
  • 7th Neurosurgery  
  • 7th Ophthalmology  
  • 9th Family Medicine    
  • 10th Psychiatry    
  • 10th Genetics  

As the largest public funder of biomedical research globally, the NIH plays a crucial role in advancing health for all. By investing in institutions like Duke, the NIH fuels scientific research and translates knowledge into tangible improvements for patients.